Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Digital Psychotherapeutics Market

Digital Psychotherapeutics Market Trends

Report ID: GMI7175
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Digital Psychotherapeutics Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as increase in adoption of teletherapy, growing demand for mental health apps, and virtual reality (VR) therapy.

Artificial intelligence (AI) in healthcare and chatbot integration into mental health applications and platforms provide automated help, advice, and interventions. These AI-powered systems seek to provide personalized mental health care to the user.
Moreover, wearable medical devices, such as fitness trackers and smartwatches, began to integrate mental health monitoring and intervention features to provide a more holistic approach to well-being. In addition, healthcare institutions and providers are progressively integrating digital psychotherapy services into their service offerings, making them more broadly available to patients and a frequent part of comprehensive treatment initiatives

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Digital psychotherapeutics industry reached around USD 1.2 billion in revenue in 2022 and is projected to be worth USD 16.9 billion by 2032 owing to the rising prevalence of psychological disorders and the surging demand for accessible and effective treatment choices.

The combination therapy segment generated USD 836 million in 2022 and is estimated to witness high demand through 2032 attributed to its improved treatment efficacy.

North America digital psychotherapeutics industry amassed USD 700.3 million in revenue in 2022 and is set to witness robust growth through 2032 with the increasing mental health awareness and the growing recognition of the importance of mental well-being in the region.

The competitive landscape of the digital psychotherapeutics industry includes prominent firms, such as Novartis AG, Pear Therapeutics, SilverCloud Health, Woebot Health, Starling Minds, SwissDT, AbleTo, Inc., Spring Care, Inc, Meru, and Ginger.